Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
18.57
-0.15 (-0.80%)
At close: Sep 20, 2024, 3:54 PM
18.43
-0.14 (-0.75%)
After-hours: Sep 20, 2024, 4:01 PM EDT
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PHAT stock have an average target of 22.5, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 21.16% from the current stock price of 18.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PHAT stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +40.01% | Sep 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +40.01% | Sep 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +40.01% | Aug 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +40.01% | Aug 23, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +40.01% | Aug 19, 2024 |
Financial Forecast
Revenue This Year
45.09M
from 682.00K
Increased by 6,512.02%
Revenue Next Year
177.12M
from 45.09M
Increased by 292.78%
EPS This Year
-6.05
from -3.93
EPS Next Year
-4.59
from -6.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 53.0M | 264.3M | 527.5M | ||
| Avg | 45.1M | 177.1M | 387.5M | ||
| Low | 38.2M | 133.4M | 268.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7,672.1% | 486.1% | 197.8% | ||
| Avg | 6,512.0% | 292.8% | 118.8% | ||
| Low | 5,494.3% | 195.8% | 51.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.87 | -3.40 | -0.34 | ||
| Avg | -6.05 | -4.59 | -2.31 | ||
| Low | -6.27 | -6.58 | -3.36 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.